Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Nabs $10M in Series F Round; Mouse Protein Chip Due in April

NEW YORK, Feb. 12 (GenomeWeb News) - Protein biochip company Zyomyx has raised $10 million in a Series F round of private-equity financing, the company said today.


Zyomyx said it plans to use the cash to continue developing its protein chip technology. It expects to launch its Murine Cytokine Biochip in April 2004.

 

CSFB Private Equity led the round with existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners, Bio*One Capital, and the Biomedical Sciences investment arm of the Singapore Economic Development Board.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.